NYSE · Medical - Distribution

MCK (MCK) Stock

$906.77 +2.42% NYSE: MCK Healthcare

Valuation

MetricValue
Price$906.77
Market Cap$106.16B
P/E Ratio23.89
P/B Ratio-25.10
P/S Ratio0.26
EPS (TTM)$38.38
52-Week High$999.00
52-Week Low$677.28
Dividend Yield0.42%

Financials & Margins

MetricValue
ROE-194.39%
ROA5.20%
ROCE37.02%
Gross Margin1.54%
Operating Margin1.54%
Net Margin1.12%
Debt/Equity-2.76
Current Ratio0.85

Annual Financials (USD)

Metric20222023202420252026
Revenue$264.0B$276.7B$309.0B$359.1B$403.4B
Operating Profit$2.7B$4.5B$3.9B$4.4B$6.5B
Net Profit$1.1B$3.6B$3.0B$3.3B$4.8B
EPS$7.23$25.04$22.39$25.72$38.38
Op Margin1.0%1.6%1.3%1.2%1.6%

Balance Sheet (USD)

Metric20222023202420252026
Total Assets$63.3B$62.3B$67.4B$75.1B$82.3B
Total Liabilities$65.1B$63.8B$69.0B$76.8B$83.2B
Cash$3.5B$4.7B$4.6B$5.7B$4.0B
Borrowings$7.5B$7.3B$7.4B$7.4B$8.6B

Latest News

2 Profitable Stocks Worth Investigating and 1 We Turn Down StockStory · Jul 15, 2026 McKesson (MCK) Stock Dips While Market Gains: Key Facts Zacks · Jul 14, 2026 Cheniere Appoints Britt Vitalone to Board of Directors Business Wire · Jul 14, 2026 Leerink Partners Adjusts Price Target on McKesson to $950 From $970, Maintains Outperform Rating MT Newswires · Jul 14, 2026 Zacks Industry Outlook McKesson, Cardinal, West Pharmaceutical, Align and Henry Zacks · Jul 14, 2026

Cash Flow (USD)

Metric20222023202420252026
Operating Cash Flow$4.4B$5.2B$4.3B$6.1B$6.2B
Investing Cash Flow$-624.0M$-1.1B$-1.8B$-1.6B$-4.2B
Financing Cash Flow$-4.9B$-4.0B$-3.2B$-3.7B$-5.1B
Net Cash Flow$-2.5B$744.0M$-94.0M$1.4B$-2.0B
Free Cash Flow$3.9B$4.6B$3.6B$5.2B$5.4B

Valuation & Return Ratios

MetricValue
PEG Ratio0.49
EV / EBITDA15.61
FCF Yield5.89%
Quick Ratio0.52
Interest Coverage43.49
Return 1Y31.72%
Return 3Y114.78%
Return 5Y327.79%

Ownership

Insiders Held0.05%
Institutions Held95.69%
Institutions Float Held95.74%
Institutional HolderSharesReport Date
Blackrock Inc.11,418,3842026-03-31
Vanguard Capital Management LLC7,960,7242026-03-31
State Street Corporation5,731,7562026-03-31
FMR, LLC3,603,4232026-03-31
JPMORGAN CHASE & CO3,268,3402026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BMY $66.92 +0.16% 14.88 $136.70B 3.73%
CAH $239.35 +2.02% 32.79 $56.06B 0.86%
COR $330.97 +2.28% 23.93 $64.39B 0.74%
CVS $97.60 +3.93% 24.63 $124.53B 2.82%
GSKGSK plc $51.58 9.28 $103.73B 3.49%

About MCK

MCK is led by CEO Brian S. Tyler, employs 44,000 people, headquartered in Irving, US, publicly traded since 1994.

MCK stock trades at $906.77 with a market capitalization of $106.16B. The stock is valued at a price-to-earnings (P/E) ratio of 23.89, price-to-book of -25.10, price-to-sales of 0.26. Over the past 52 weeks the stock has ranged between $677.28 and $999.00, and currently trades 9.2% below its 52-week high. It pays a dividend yielding 0.42%.

On profitability, MCK generates a return on equity (ROE) of -194.39%, return on capital employed of 37.02%, an operating margin of 1.54%, a net profit margin of 1.12%.

In its most recent fiscal year, MCK reported annual revenue of $403.4B, net profit of $4.8B, revenue has compounded at 11.1% a year over the last five years.

The balance sheet shows a debt-to-equity ratio of -2.76 — a conservative balance sheet with little leverage risk, a current ratio of 0.85, total assets of $82.3B, $4.0B in cash and equivalents.

MCK has a beta of 0.31 (less volatile than the overall market).

Related Healthcare Stocks

LLY Drug Manufacturers - General $1159.93 +0.28% JNJ Drug Manufacturers - General $271.19 +2.01% ABBV Drug Manufacturers - General $259.99 +1.39% MRK Drug Manufacturers - General $149.94 +1.48% UNH Medical - Healthcare Plans $396.30 +1.77% NVS Drug Manufacturers - General $161.25 +6.04% AZN Drug Manufacturers - General $162.47 +0.21% AMGN Drug Manufacturers - General $438.12 +1.92% TMO Medical - Diagnostics & Research $600.50 -2.69% NVO Biotechnology $45.12 -0.46% ABT Medical - Devices $108.97 -1.26% GILD Drug Manufacturers - General $149.92 +2.45%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides